Page 436 - 16Neonatal Jaundice_compressed

Appendix H: Evidence tables

Bibliographic Study Type & Number of Intervention & Comparison Dichotomous outcomes Continuous Outcomes
Information Evidence Level Patients/Characteristics (E:C) (Mean:SD: N)
Year: Blinding: Inclusion: Group 2:
1986 Not reported Preterm babies with gestational Phototherapy with Chest shields Late mortality
age between 26 and 32 weeks Group 1: 4/38
Country: Randomisation: All babies were receiving early Group 2: 10/36
USA Randomisation chart Exclusion: phototherapy to prevent
None hyperbilirubinaemia and were nursed
184
ID: Evidence level: under radiant warmers, receive
1 + Demographics: mechanical ventilation for respiratory
Gender (M/F):Not reported distress syndrome.
Mean GA: 29.4 weeks
Mean BW: 2034 g Standard phototherapy units (Air
Mean age at entry to study: Not Shields) were used Mean light intensity
reported was 4.77 microwatt/cm² per nm
Mean TSB: micromol/litre
Chest shields were folded (doubled)
piece of aluminium foil covered in a
gauze pad and taped over the left chest.
Author: Methodology: N: Phototherapy consisted of standard unit Mean change in Lymphocyte-DNA damage
Tatli M Comparative study 47 (14 were healthy controls) of 4 blue and 2 white fluorescent tubes PT: 29.1 ± 1.9
with healthy controls (Air Shields) with a light range of 480 –
Year: Inclusion: 520 nm and an irradiance of Control: 2.7 ± 2.9
2008 Blinding: Term babies with non- 12 microwatt/cm² per nm. Phototherapy
None haemolytic hyperbilirubinaemia
Country: lasted 72 hours, babies whose TsB
Turkey Randomisation: Exclusion: declined to normal levels before
None None 72 hours were excluded.

178
ID:
Evidence level: Demographics:
2 - Gender (M/F):29/18
Mean GA: 39.3 ± 0.9 weeks
Mean BW: 3021 ± 450 g
Mean age at entry to study:
113 ± 46 hours
Mean TSB: Not reported
Author: Methodology: N: PT No increased risk of developing childhood malignant melanoma
Berg P Retrospective 150 Cases: 0/30 in skin of babies who received phototherapy
matched case–control Controls: 11/120
Year: study Inclusion:
1997 30 cases of childhood cancer
Blinding: before 20 years of age and 120
Country: None controls
Sweden
Randomisation: Exclusion:
180
ID: None None

Evidence level: Demographics:

291